BioMarin Pharmaceutical Inc. (BVMF:B1MR34)

BioMarin Pharmaceutical Revenue

BioMarin Pharmaceutical had revenue of $776.13M USD in the quarter ending September 30, 2025, with 4.08% growth. This brings the company's revenue in the last twelve months to $3.09B, up 12.39% year-over-year. In the year 2024, BioMarin Pharmaceutical had annual revenue of $2.85B with 17.97% growth.

• Revenue (ttm): $3.09B
• Revenue Growth: +12.39%
• P/S Ratio: 3.41
• Revenue / Employee: $1.02M
• Employees: 3,040
• Market Cap: 56.28B BRL

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.85B	434.69M	17.97%
Dec 31, 2023	2.42B	323.19M	15.42%
Dec 31, 2022	2.10B	249.76M	13.53%
Dec 31, 2021	1.85B	-14.18M	-0.76%
Dec 31, 2020	1.86B	156.41M	9.18%